Financial Daily from THE HINDU group of publications
Friday, Mar 05, 2004
News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

 Corporate - People


Saran Narang on Nicholas Piramal board

Our Bureau

New Delhi , March 4

Dr Saran Narang, a well-known molecular biologist and Principal Research Officer of the Genetic Research Programme at the National Research Council of Canada, has been appointed to Nicholas Piramal Scientific Advisory Board.

At Nicholas Piramal, Dr Narang will work on the current Cancer Research Programme.

More Stories on : People | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Thomas Cook plans outbound charters

$ 6-b ECB money likely to flood markets — Cos seeking 'change in lender profile, lower interest cost'
Bombay Dyeing rating reaffirmed
Total to take 26 pc stake in Shell Hazira
Apollo Tyres in talks again to buy Modi Rubber
Haier buys out entire stake in Indian unit
Shrenuj to set up third jewellery unit
Dr Batra's mulls clinics in Kolkata, Guwahati
GGS India arm to expand
IOC ties up LNG sale with Essar Steel
Novartis AG seeks tie-ups with Indian companies
Wipro inks pact with Brillian
BEL aid to centre for disabled
Sanwaria Agro board clears power sector foray
Marico mulls bonus issue again
Phillips Carbon aims at Rs 1,000-cr turnover
Saran Narang on Nicholas Piramal board

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line